Mayank Mamtani

Stock Analyst at B. Riley Securities

(0.9)
# 2172
Out of 5,338 analysts
175
Total ratings
33.96%
Success rate
4.93%
Average return
46 Stocks
Name Action PT Current % Upside Ratings Updated
MDGL Madrigal Pharmaceuti...
Reiterates: Strong Buy
422 460
291.16 57.99% 12 May 2, 2025
HROW Harrow
Maintains: Buy
69 65
25.61 153.81% 2 Apr 1, 2025
VXRT Vaxart
Maintains: Buy
3 2
0.42 376.19% 6 Mar 27, 2025
TRVI Trevi Therapeutics
Reiterates: Strong Buy
11 20
6.18 223.62% 3 Mar 19, 2025
LCTX Lineage Cell Therape...
Maintains: Buy
4 3
0.47 538.3% 2 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38 35
14.15 147.35% 2 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
51 38
15.34 147.72% 7 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 96
27.39 250.49% 2 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.68 488.24% 1 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
1 2
0.32 368.75% 3 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
23 26
6.29 313.35% 19 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
n/a n/a 4 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
12.61 161.7% 1 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
5.79 245.42% 9 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 34
33.57 1.28% 13 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 5
1.54 224.68% 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
122 92
29.82 208.52% 3 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 33
n/a n/a 7 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
4.16 -3.85% 3 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 4
n/a n/a 5 Nov 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
140
4.12 3298.06% 1 Oct 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 19
n/a n/a 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
210 90
3.02 2880.13% 5 Apr 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
160
3.37 4647.77% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
2 1
n/a n/a 4 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 5
1.8 177.78% 3 Aug 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
58 44
2.05 2046.34% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
120 90
1.77 4984.75% 4 Jul 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 7
7.33 -4.5% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
600 450
n/a n/a 1 Mar 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
850 500
n/a n/a 1 Mar 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1
n/a n/a 6 Mar 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 8
n/a n/a 2 Mar 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23040 15360
n/a n/a 2 Mar 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9750 4500
1.12 401685.71% 3 Jan 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 270
1.07 25133.64% 2 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
n/a n/a 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
138 77
11.59 564.37% 2 Jan 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
96
n/a n/a 2 Jul 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1980 1440
1.29 111527.91% 3 May 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
1.32 203.03% 2 Apr 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
70 30
n/a n/a 2 Apr 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
47 39
96.59 -59.62% 2 Mar 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
22 11
1.37 702.92% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 34
3.92 767.35% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 20
n/a n/a 1 Dec 10, 2019